[Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors]
- PMID: 27778054
- DOI: 10.1007/s00101-016-0240-x
[Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors]
Comment on
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.N Engl J Med. 2016 Sep 22;375(12):1131-41. doi: 10.1056/NEJMoa1607887. Epub 2016 Aug 30. N Engl J Med. 2016. PMID: 27573206 Free PMC article. Clinical Trial.
Similar articles
-
Andexanet alfa for reversal of factor Xa inhibitors: a critical review of the evidence.Future Cardiol. 2019 Nov;15(6):395-404. doi: 10.2217/fca-2019-0038. Epub 2019 Oct 31. Future Cardiol. 2019. PMID: 31668083 Review.
-
Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.N Engl J Med. 2016 Sep 22;375(12):1131-41. doi: 10.1056/NEJMoa1607887. Epub 2016 Aug 30. N Engl J Med. 2016. PMID: 27573206 Free PMC article. Clinical Trial.
-
Andexanet alfa for the reversal of factor Xa inhibitors.Expert Opin Biol Ther. 2019 May;19(5):387-397. doi: 10.1080/14712598.2019.1599355. Epub 2019 Apr 11. Expert Opin Biol Ther. 2019. PMID: 30974977 Review.
-
Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.J Thromb Thrombolysis. 2018 Apr;45(3):345-352. doi: 10.1007/s11239-018-1617-2. J Thromb Thrombolysis. 2018. PMID: 29372400 Review.
-
Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.Expert Rev Cardiovasc Ther. 2017 Apr;15(4):237-245. doi: 10.1080/14779072.2017.1305889. Epub 2017 Mar 22. Expert Rev Cardiovasc Ther. 2017. PMID: 28282497 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources